Jorge-Araújo Adrian Camargo Amaral, Bortoluzzi Marcelo Carlos, Baratto-Filho Flares, Santos Fábio André, Pochapski Márcia Thaís
Department of Dentistry, UEPG - Universidade Estadual de Ponta Grossa, Ponta Grossa, PR, Brazil.
Department of Dentistry, UP - Universidade Positivo, Curitiba, PR, Brazil.
Braz Dent J. 2018 May-Jun;29(3):254-260. doi: 10.1590/0103-6440201801786.
In spite of advances in root canal therapy and better knowledge of pulpal and periapical inflammation, up 40% of endodontic patients report varying degrees of pain. The aim of this present study was to compare the effect of single preoperative dose of ibuprofen or dexamethasone on post-endodontic pain. Sixty volunteers were divided into three groups (n=20 per group): PL, placebo; IB, 400 mg of ibuprofen; and DE, 8 mg of dexamethasone. The primary outcome was the post-endodontic pain intensity measured with a numerical rating scale (4, 8, 12, 24, and 48 h). Secondary outcomes included number of anesthetic cartridges used and consumption of rescue medication. Data were analyzed by one-way ANOVA, chi-square and Kruskal-Wallis tests. There was no significant difference among groups (p>0.05) considering the pain intensity. Only 37% of IB group patients and 28% of DE group patients used some rescue medication. On the other hand, 74% of PL group patients mentioned the consumption of rescue medication; PL group had a statistically significant difference (p<0.05) in comparison with IB and DE groups. The number of anesthetic cartridges used had no statistically significant difference among the groups (p>0.05). Significant differences were not found in the reduction of pain intensity and the number of anesthetic cartridges used. Considering the consumption of rescue medication (secondary outcome), preoperative administration of Ibuprofen or dexamethasone reduces post-endodontic pain and discomfort in comparison with a placebo. Premedication with anti-inflammatory drugs drugs could be contributed to control of the post-endodontic pain, mainly in patients more sensible for pain.
尽管根管治疗技术有所进步,并且对牙髓和根尖周炎症有了更深入的了解,但仍有高达40%的牙髓病患者报告有不同程度的疼痛。本研究的目的是比较术前单次服用布洛芬或地塞米松对根管治疗后疼痛的影响。60名志愿者被分为三组(每组n = 20):PL组,安慰剂组;IB组,400毫克布洛芬组;DE组,8毫克地塞米松组。主要观察指标是用数字评分量表测量的根管治疗后疼痛强度(4、8、12、24和48小时)。次要观察指标包括使用的麻醉药筒数量和急救药物的消耗量。数据采用单因素方差分析、卡方检验和Kruskal-Wallis检验进行分析。考虑到疼痛强度,各组之间没有显著差异(p>0.05)。IB组只有37%的患者和DE组28%的患者使用了一些急救药物。另一方面,PL组74%的患者提到使用了急救药物;与IB组和DE组相比,PL组有统计学显著差异(p<0.05)。各组使用的麻醉药筒数量没有统计学显著差异(p>0.05)。在疼痛强度降低和使用的麻醉药筒数量方面未发现显著差异。考虑到急救药物的消耗量(次要观察指标),与安慰剂相比,术前服用布洛芬或地塞米松可减轻根管治疗后的疼痛和不适。术前使用抗炎药物有助于控制根管治疗后的疼痛,主要是对疼痛更敏感的患者。